Subscribe To
LMNL / Liminal BioSciences stock rockets on take-private deal with a fund managed by Thomvest Asset Management
Content Topics
Liminal
Biosciences
Stock
Rockets
Take
Private
Deal
With
Take private
Managed
Thomvest
Management
LMNL
LMNL News
By Zacks Investment Research
July 13, 2023
Liminal (LMNL) Up 40% on Buyout Offer From Majority Shareholder
If the minority shareholders of Liminal BioSciences (LMNL) accept the buyout offer, they will receive $8.50 per share. This offer is a dollar more tha more_horizontal
By Market Watch
July 12, 2023
Liminal BioSciences stock rockets on take-private deal with a fund managed by Thomvest Asset Management
Liminal BioSciences Inc. LMNL, -1.33% stock is rallying 41.7% in premarket trades on Wednesday after the company said it agreed to go private at a pri more_horizontal
By InvestorPlace
April 5, 2023
Why Is Liminal Biosciences (LMNL) Stock Up 77% Today?
Liminal Biosciences (NASDAQ: LMNL ) stock is taking off on Wednesday as investors react to the biopharmaceutical company getting an unsolicited transa more_horizontal
By Market Watch
April 5, 2023
Liminal Biosciences' stock soars 91% after getting takeover offer that's more than double its price
Liminal Biosciences Inc.'s stock LMNL, -4.23% soared 91% in premarket trade Wednesday, after the company said it's received an unsolicited takeover of more_horizontal
By Seeking Alpha
March 17, 2023
Liminal BioSciences Inc. (LMNL) Q4 2022 Earnings Call Transcript
Liminal BioSciences Inc. (NASDAQ:LMNL ) Q4 2022 Results Conference Call March 16, 2023 8:30 AM ET Company Participants Shrinal Inamdar - IR Bruce Prit more_horizontal
By PRNewsWire
January 19, 2023
Liminal BioSciences to Present at BIO CEO & Investor Conference
LAVAL, QC and CAMBRIDGE, England , Jan. 19, 2023 /PRNewswire/ - Liminal BioSciences Inc. (Nasdaq: LMNL) ("Liminal BioSciences" or the "Company"), ann more_horizontal
By Seeking Alpha
November 13, 2022
Liminal Biosciences (LMNL) Q3 2022 Earnings Call Transcript
Liminal Biosciences (NASDAQ:LMNL ) Q3 2022 Earnings Conference Call November 10, 2022 8:30 AM ET Company Participants Shrinal Inamdar - Investor Relat more_horizontal
By Seeking Alpha
May 13, 2022
Liminal BioSciences Inc. (LMNL) CEO Bruce Pritchard on Q1 2022 Results - Earnings Call Transcript
Liminal BioSciences Inc. (NASDAQ:LMNL ) Q1 2022 Earnings Conference Call May 11, 2022 8:30 AM ET Company Participants Shrinal Inamdar - Investor Relat more_horizontal